Therefore, the main objective of this study is to clarify the role of iNOS/NO in CRC, by studying whether iNOS acts as an intermediate in the ability of PARP-1 to regulate the phenotype of CSCs. This evidence concerns the gene NOS2 and colorectal carcinoma.